Chugai Pharmaceutical—discloses consolidated earnings forecast for fiscal year ending December 2026 (under IFRS) [DZH individual stock information] (Jiji Press)

The story

Chugai Pharmaceutical announced that consolidated revenue for the fiscal year ending December 2026 is expected to generate a profit of ¥1.34 trillion.

These figures are based on IFRS and represent the outlook disclosed by the company.

At a glance

CompanyChugai Pharmaceutical (pronounced: Chugai Pharmaceutical)

TimingOutlook for the fiscal year ending December 2026

MagnitudeConsolidated revenue expected to be ¥1.34 trillion, with a profit

NatureForecast disclosure under IFRS

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

finance.yahoo.co.jpNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.